Arkolith/Insider Trading/GCTK/Form 4

Carter Erin Catherine

DirectorGlucotrack, Inc. (GCTK) · full profile →Form 4 · filed Mar 31, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
5 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 26, 2025Grant(A)2K—$046K
Mar 12, 2025Option exercise(X)40K—$044K
Nov 14, 2024Conversion(C)2K$31.20$65K3K
Apr 8, 2024Grant(A)458—$01K
Dec 31, 2023Grant(A)903—$0903

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 12, 2025Option exercise(X)0—$0—
Nov 14, 2024Grant(A)2K——2K
Nov 14, 2024Conversion(C)2K$64831.00$134.7M2K
Nov 14, 2024Grant(A)0——0
Jul 18, 2024Buy(P)2K$50000.00$103.9M0

Transaction Codes

A
Grant / award
X
Exercise of in-the-money derivative
C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001474506-25-000070) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML